Veraxa Biotech Holding AG (VRXA) Total Current Liabilities (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has reported Total Current Liabilities for 2 consecutive years, with $8.3 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Total Current Liabilities rose 184.71% year-over-year to $8.3 million; the trailing twelve-month figure through Dec 2025 stood at $8.3 million (up 184.71% YoY), and the FY2025 full-year result was $8.3 million, up 184.71% from the prior year.
• Total Current Liabilities advanced to $8.3 million in Q4 2025 per VRXA's latest filing, from $2.9 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $8.3 million in Q4 2025 to a low of $2.9 million in Q4 2024.